Pharma Co. Sued For $12M For Underpaying Board Chair

By Katryna Perera · April 29, 2022, 7:34 PM EDT

Altum Pharmaceuticals and its cannabis-focused parent company were hit with a $12 million suit Thursday, accusing the companies and several executives of self-dealing and stock dilution and underpaying the executive chairman...

To view the full article, register now.